文献速递术前评估与围术期医学疼痛医学

美国大型骨科手术围术期苯二氮䓬类药物使用情况

The Perioperative Use of Benzodiazepines for Major Orthopedic Surgery in the United States.
PubMed 文献 · Anesth Analg · 2022-01-01

基于2006-2019年Premier医疗索赔数据,纳入1,863,996例全膝关节置换和985,471例全髋关节置换患者,描述围术期苯二氮䓬使用模式。结果显示全膝关节置换使用率80.5%,全髋关节置换76.1%,且使用与术后阿片类药物用量显著增加相关。

要点

  • 美国大型骨科手术中约4/5患者围术期接受苯二氮䓬类药物。
  • 苯二氮䓬使用与术后阿片类药物用量显著增加相关,长效者更明显。
  • 年轻、白人、商业保险、椎管内麻醉及中小型医院患者使用更频繁。

核心结论

  • 基于代表性样本,美国4/5的大型骨科手术患者围术期接受苯二氮䓬类药物,尽管存在谵妄和术后神经认知恢复延迟的担忧。
  • 苯二氮䓬使用与术后阿片类药物用量显著增加相关,可能对围术期疼痛管理有影响。

研究设计与样本

  • 回顾性队列研究,使用Premier Healthcare索赔数据(2006-2019年),纳入1,863,996例全膝关节置换和985,471例全髋关节置换患者。
  • 苯二氮䓬使用按长效和短效分层,通过患者和医疗特征及镇痛方案评估,使用标准化差异(>0.1)表示组间有意义差异。

主要发现

  • 全膝关节置换中苯二氮䓬使用率为80.5%,全髋关节置换为76.1%。
  • 全膝关节置换中短效苯二氮䓬使用率72.6%,长效7.9%;全髋关节置换中分别为68.4%和7.7%。
  • 使用苯二氮䓬的患者中,术后住院阿片类药物用量(口服吗啡当量)显著更高:无苯二氮䓬中位数192(IQR 83-345),短效256(IQR 153-431),长效329(IQR 195-540)。
  • 苯二氮䓬使用在年轻患者、白人患者、商业保险、接受椎管内麻醉、中小型医院(≤500床)和中西部地区的患者中更频繁(标准化差异≥0.1)。
  • 趋势分析显示过去14年苯二氮䓬使用率持续居高。

临床怎么用

  • 围术期苯二氮䓬使用普遍,临床医生应权衡风险(谵妄、神经认知恢复延迟)与获益,尤其老年患者。
  • 苯二氮䓬使用与术后阿片用量增加相关,疼痛管理方案中需考虑此相互作用。
  • 可关注高危使用模式(如长效制剂、特定人群)以优化围术期用药。

局限性

  • 基于索赔数据,可能缺乏临床细节和用药指征信息。
  • 观察性设计无法确定因果关系。
  • 样本代表美国部分医院,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite numerous indications for perioperative benzodiazepine use, associated risks may be exacerbated in elderly and comorbid patients. In the absence of national utilization data, we aimed to describe utilization patterns using national claims data from total hip/knee arthroplasty patients (THA/TKA), an increasingly older and vulnerable surgical population. METHODS: We included data on 1,863,996 TKAs and 985,471 THAs (Premier Healthcare claims data, 2006-2019). Benzodiazepine utilization (stratified by long- and short-acting agents) was assessed by patient- and health care characteristics, and analgesic regimens. Given the large sample size, standardized differences instead of P values were utilized to signify meaningful differences between groups (defined by value >0.1). RESULTS: Among 1,863,996 TKA and 985,471 THA patients, the utilization rate of benzodiazepines was 80.5% and 76.1%, respectively. In TKA, 72.6% received short-acting benzodiazepines, while 7.9% received long-acting benzodiazepines, utilization rates 68.4% and 7.7% in THA, respectively. Benzodiazepine use was particularly more frequent among younger patients (median age [interquartile range {IQR}]: 66 [60-73]/64 [57-71] among short/long-acting compared to 69 [61-76] among nonusers), White patients (80.6%/85.4% short/long-acting versus 75.7% among nonusers), commercial insurance (36.5%/34.0% short/long-acting versus 29.1% among nonusers), patients receiving neuraxial anesthesia (56.9%/56.5% short/long-acting versus 51.5% among nonusers), small- and medium-sized (≤500 beds) hospitals (68.5% in nonusers, and 74% and 76.7% in short- and long-acting benzodiazepines), and those in the Midwest (24.6%/25.4% short/long-acting versus 16% among nonusers) in TKA; all standardized differences ≥0.1. Similar patterns were observed in THA except for race and comorbidity burden. Notably, among patients with benzodiazepine use, in-hospital postoperative opioid administration (measured in oral morphine equivalents [OMEs]) was substantially higher. This was even more pronounced in patients who received long-acting agents (median OME with no benzodiazepines utilization 192 [IQR, 83-345] vs 256 [IQR, 153-431] with short-acting, and 329 [IQR, 195-540] with long-acting benzodiazepine administration). Benzodiazepine use was also more frequent in patients receiving multimodal analgesia (concurrently 2 or more analgesic modes) and regional anesthesia. Trend analysis showed a persistent high utilization rate of benzodiazepines over the last 14 years. CONCLUSIONS: Based on a representative sample, 4 of 5 patients undergoing major orthopedic surgery in the United States receive benzodiazepines perioperatively, despite concerns for delirium and delayed postoperative neurocognitive recovery. Notably, benzodiazepine utilization was coupled with substantially increased opioid use, which may project implications for perioperative pain management.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Cozowicz C, Zhong H, Illescas A, et al. The Perioperative Use of Benzodiazepines for Major Orthopedic Surgery in the United States. Anesth Analg. 2022. PMID: 35180165. doi:10.1213/ANE.0000000000005854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。